Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer
Authors
Keywords
-
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 68, Issue 5, Pages 1291-1304
Publisher
Springer Nature
Online
2011-03-29
DOI
10.1007/s00280-011-1618-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The inhibition of Aurora A abrogates the mitotic delay induced by microtubule perturbing agents
- (2011) Deborah R. Wysong et al. CELL CYCLE
- Drug-Resistant Aurora A Mutants for Cellular Target Validation of the Small Molecule Kinase Inhibitors MLN8054 and MLN8237
- (2010) Dominic A. Sloane et al. ACS Chemical Biology
- Unholy Matrimony: Aurora A and N-Myc as Malignant Partners in Neuroblastoma
- (2009) John M. Maris CANCER CELL
- Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma
- (2009) Tobias Otto et al. CANCER CELL
- Small Molecule Aurora Kinases Inhibitors
- (2009) Laura Garuti et al. CURRENT MEDICINAL CHEMISTRY
- Aurora-A down-regulates IkappaBα via Akt activation and interacts with insulin-like growth factor-1 induced phosphatidylinositol 3-kinase pathway for cancer cell survival
- (2009) Jin-e Yao et al. Molecular Cancer
- Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma
- (2009) X. Shang et al. MOLECULAR CANCER THERAPEUTICS
- UA62784, a novel inhibitor of centromere protein E kinesin-like protein
- (2009) M. C. Henderson et al. MOLECULAR CANCER THERAPEUTICS
- Reference alignment of SNP microarray signals for copy number analysis of tumors
- (2008) Stan Pounds et al. BIOINFORMATICS
- Aurora Kinase A Inhibition Leads to p73-Dependent Apoptosis in p53-Deficient Cancer Cells
- (2008) Altaf A. Dar et al. CANCER RESEARCH
- Aurora Kinases as Anticancer Drug Targets
- (2008) O. Gautschi et al. CLINICAL CANCER RESEARCH
- Molecular Characterization of the Pediatric Preclinical Testing Panel
- (2008) G. Neale et al. CLINICAL CANCER RESEARCH
- Aurora-A Kinase Is Essential for Bipolar Spindle Formation and Early Development
- (2008) D. O. Cowley et al. MOLECULAR AND CELLULAR BIOLOGY
- EWS-Fli1 Up-Regulates Expression of the Aurora A and Aurora B Kinases
- (2008) K. Wakahara et al. MOLECULAR CANCER RESEARCH
- Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery
- (2008) Libor Macůrek et al. NATURE
- Bora and the Kinase Aurora A Cooperatively Activate the Kinase Plk1 and Control Mitotic Entry
- (2008) A. Seki et al. SCIENCE
- Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program
- (2007) Peter J. Houghton et al. PEDIATRIC BLOOD & CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started